Pelvic organ mobility after treatment for uterine descent

Pelvic organ mobility after treatment for uterine descent - Mobility after treatment

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41071

Enrollment

Registered

2014-08-19

Start date

2014-11-03

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prolapse uterine descent

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who recently underwent a vaginal hysterectomy, vaginal sacrospinous hysteropexy and laparoscopic sacrohysteropexy as a primary treatment for uterine descent (without surgery for prolapse or hysterectomy in the past)

Exclusion criteria

Exclusion criteria: Factors that will preclude MRI interpretation (e.g. prosthetic hip) Contra-indications for MRI (e.g. claustrophobia, metal clips) Not physically able to maintain Valsalva maneuvre for at least 10 seconds (e.g. pulmonary problems) Neurological disease affecting the pelvic floor Previous pelvic floor surgery

Design outcomes

Primary

Measure	Time frame
Primary outcome is the mobility of the pelvic organs (displacement of the bladder, vagina, cervix or apex and rectum) between three commonly performed treatment options for uterine descent.	—

Secondary

Measure	Time frame
Secondary outcome is the correlation between the clinical results (MRI findings, POP-Q assessment) and symptoms of POP.	—

Countries

Netherlands

Outcome results